Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018
44:31
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
1:19:35
Chemistry, Manufacturing, and Controls (CMC) for an IND (7of14) REdI 2018
4:38:30
FDA Clinical Investigator Training Course (CITC) 2024 (Day 1 of 3)
55:56
Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI – May 29-30, 2019
1:57:16
M13A: Bioequivalence for Immediate-Release Solid Oral Dosage Forms - Implementing the Final Guidance
1:57:53
Clinical Pharmacology Considerations for Novel Therapeutic Modalities
1:20:20
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
40:26